Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1)
Phase 2 other active
Quick answer
Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1) for Limited metastatic pancreatic cancer is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Limited metastatic pancreatic cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active